Evaluating Prognosis of Acute Ischemic Stroke through Serum Biomarkers
Author Information
Author(s): Tahir Yoldas, Murat Gonen, Ahmet Godekmerdan, Fulya Ilhan, Ednan Bayram
Primary Institution: Firat University
Hypothesis
The study investigates the relationship between serum hsCRP and homocysteine levels and the short-term prognosis of patients with acute ischemic stroke.
Conclusion
Patients with stroke have higher serum hsCRP and homocysteine levels, with elevated hsCRP levels being associated with a short-term unfavorable prognosis.
Supporting Evidence
- The mean hsCRP levels of patients were significantly higher than those of healthy controls.
- 72.5% of patients had homocysteine levels higher than 15 μmol/L compared to 25% of controls.
- Patients who could walk independently had lower hsCRP levels than those who died.
Takeaway
This study found that people who have a stroke have higher levels of certain substances in their blood, which can help doctors understand how serious the stroke is.
Methodology
The study measured hsCRP and homocysteine levels in 40 stroke patients at multiple time points and compared them to 40 healthy controls.
Potential Biases
Potential bias due to exclusion of patients with other health issues that could affect results.
Limitations
The study did not include patients with certain pre-existing conditions or those who improved quickly after the stroke.
Participant Demographics
Mean age of patients was 69 ± 11 years; control group mean age was 70 ± 9 years.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website